Abstract
Background
The National Institute of Neurological Disorders and Stroke (NINDS) Common Data Elements (CDEs) have been generated to standardize and define terms used by the scientific community. The widespread use of these CDEs promotes harmonized data collection in clinical research. The aim of the NINDS Unruptured Intracranial Aneurysms (UIA) and Subarachnoid Hemorrhage (SAH), and Subject Characteristics working group (WG) was to identify, define, and classify CDEs describing the characteristics of patients diagnosed with an UIA and SAH. Thus, “Participant/Subject characteristics” is a set of factors defining a population of selected individuals and allowing comparisons with a reference population and overtime.
Methods
Based on standard terms defined by the United States’ Census Bureau, CDEs previously defined by several (Stroke, Epilepsy and Traumatic Brain Injury) NINDS CDE working groups literature and expert opinion of the WG, the “Participant/Subject characteristics” domain has been defined.
Results
A set of 192 CDEs divided in 7 subsections: demographics (8 CDEs), social status (8 CDEs), behavioral status (22 CDEs), family and medical history (144 CDEs), pregnancy and perinatal history (8 CDEs), history data source reliability (3 CDEs), and prior functional status (3 CDEs) was defined. SAH is characterized by 6 core elements, all classified in the “Participant/Subject characteristics” domain. Four exploratory elements out of the 39 for SAH overall are in the “Participant/Subject characteristics” domain, and all remaining 182 CDEs in the “Participant/Subject characteristics” domain are classified as Supplemental-Highly Recommended elements.
Conclusions
These CDEs would allow the development of best practice guidelines to standardize the assessment and reporting of observations concerning UIA and SAH.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Etminan N, Rinkel GJ. Unruptured intracranial aneurysms: development, rupture and preventive management. Nat Rev Neurol. 2016;12(12):699–713.
Rabinstein AA. Subarachnoid hemorrhage. Neurology. 2013;80(5):e56–9.
Damani R, Mayer S, Dhar R, Martin RH, Nyquist P, Olson DM, et al. Common data element for unruptured intracranial aneurysm and subarachnoid hemorrhage: recommendations from assessments and clinical examination workgroup/subcommittee. Neurocrit Care. 2019. https://doi.org/10.1007/s12028-019-00736-1.
Juvela S, Lehto H. Risk factors for all-cause death after diagnosis of unruptured intracranial aneurysms. Neurology. 2015;84(5):456–63.
Korja M, Lehto H, Juvela S. Lifelong rupture risk of intracranial aneurysms depends on risk factors: a prospective Finnish cohort study. Stroke. 2014;45(7):1958–63.
Juvela S, et al. Natural history of unruptured intracranial aneurysms: a long-term follow-up study. Stroke. 2013;44(9):2414–21.
Andreasen TH, et al. Modifiable risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 2013;44(12):3607–12.
Inagawa T. Risk factors for the formation and rupture of intracranial saccular aneurysms in Shimane, Japan. World Neurosurg. 2010;73(3):155–64 (discussion e23).
Heuschmann PU, et al. Ethnic group disparities in 10-year trends in stroke incidence and vascular risk factors: the South London Stroke Register (SLSR). Stroke. 2008;39(8):2204–10.
Kissela BM, et al. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke. 2002;33(5):1321–6.
Juvela S. Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage. Arch Neurol. 1996;53(8):734–40.
Juvela S, et al. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993;24(5):639–46.
Woo J, Lau E, Kay R. Elderly subjects aged 70 years and above have different risk factors for ischemic and hemorrhagic strokes compared to younger subjects. J Am Geriatr Soc. 1992;40(2):124–9.
Knekt P, et al. Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol. 1991;44(9):933–9.
Koroknay-Pal P, et al. Long-term excess mortality in pediatric patients with cerebral aneurysms. Stroke. 2012;43(8):2091–6.
Korja M, et al. Risk factors and their combined effects on the incidence rate of subarachnoid hemorrhage—a population-based cohort study. PLoS ONE. 2013;8(9):e73760.
Hishikawa T, et al. Risk of rupture of unruptured cerebral aneurysms in elderly patients. Neurology. 2015;85(21):1879–85.
Etminan N, et al. The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus. Neurology. 2015;85(10):881–9.
Tominari S, et al. Prediction model for 3-year rupture risk of unruptured cerebral aneurysms in Japanese patients. Ann Neurol. 2015;77(6):1050–9.
Lindgren AE, et al. De novo aneurysm formation in carriers of saccular intracranial aneurysm disease in Eastern Finland. Stroke. 2016;47(5):1213–8.
Etminan N, et al. Multidisciplinary consensus on assessment of unruptured intracranial aneurysms: proposal of an international research group. Stroke. 2014;45(5):1523–30.
Greving JP, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol. 2014;13(1):59–66.
Investigators UJ, et al. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012;366(26):2474–82.
Wiebers DO, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362(9378):103–10.
Broderick JP, et al. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34(6):1375–81.
Korja M, et al. Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates. Neurology. 2016;87(11):1118–23.
Korja M, et al. Cause-specific mortality of 1-year survivors of subarachnoid hemorrhage. Neurology. 2013;80(5):481–6.
Lindekleiv H, et al. Joint effect of modifiable risk factors on the risk of aneurysmal subarachnoid hemorrhage: a cohort study. Stroke. 2012;43(7):1885–9.
Shiue I, et al. Modifiable lifestyle behaviours account for most cases of subarachnoid haemorrhage: a population-based case-control study in Australasia. J Neurol Sci. 2012;313(1–2):92–4.
Miller TD, et al. Screening patients with a family history of subarachnoid haemorrhage for intracranial aneurysms: screening uptake, patient characteristics and outcome. J Neurol Neurosurg Psychiatry. 2012;83(1):86–8.
Vlak MH, et al. Trigger factors and their attributable risk for rupture of intracranial aneurysms: a case-crossover study. Stroke. 2011;42(7):1878–82.
Etminan N, et al. The impact of hypertension and nicotine on the size of ruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry. 2011;82(1):4–7.
Ruigrok YM, Buskens E, Rinkel GJ. Attributable risk of common and rare determinants of subarachnoid hemorrhage. Stroke. 2001;32(5):1173–5.
Teunissen LL, et al. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke. 1996;27(3):544–9.
Clarke M. Systematic review of reviews of risk factors for intracranial aneurysms. Neuroradiology. 2008;50(8):653–64.
Fletcher GF. Exercise in the prevention of stroke. Health Rep. 1994;6(1):106–10.
Lindgren AE, et al. Hypertension predisposes to the formation of saccular intracranial aneurysms in 467 unruptured and 1053 ruptured patients in Eastern Finland. Ann Med. 2014;46(3):169–76.
Kruyt ND, et al. Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome. J Cereb Blood Flow Metab. 2010;30(9):1577–87.
Rosengart AJ, et al. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38(8):2315–21.
Algra AM, et al. Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology. 2012;79(12):1230–6.
Acknowledgements
The views expressed here are those of the authors and do not represent those of the National Institutes of Health (NIH), the National Institute of Neurological Disorders and Stroke (NINDS) or the US Government.
Funding
Logistical support for this project was provided in part through NIH Contract HHSN271201200034C, the Intramural Research Program of the NIH, NLM, The Neurocritical Care Society and the CHI Baylor St Luke’s Medical Center in Houston, TX. The development of the NINDS SAH CDEs was made possible thanks to the great investment of time and effort of WG members and the members of the NINDS CDE Project and NLM CDE project teams participating from 2015 to 2017.
Author information
Authors and Affiliations
Consortia
Contributions
PB, AM, NUK, JM, SM, YM, MJHW, and RDBJr were involved in protocol development and manuscript writing/editing. The corresponding author confirms that authorship requirements have been met, the final manuscript was approved by ALL authors, and that this manuscript has not been published elsewhere and is not under consideration by another journal. The UIA and SAH CDEs project adhered to ethical guidelines.
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Bijlenga and Dr. Morel have received research grants from SystemsX.ch a Swiss initiative for Systems Biology and evaluated by the Swiss National Science Foundation. Dr Morita has nothing to disclose. Dr Brown has nothing to disclose. Dr Mocco reports grants and other from Stryker, grants and other from Penumbra, grants and other from Medtronic, grants and other from Microvention, personal fees and other from Imperative Care, personal fees and other from Cerebrotech, personal fees and other from Viseon, personal fees and other from Endostream, personal fees and other from Rebound Therapeutics, personal fees and other from Vastrax, personal fees and other from Blink TBI, personal fees and other from Serenity, personal fees and other from NTI, personal fees and other from Neurvana, personal fees, and other from Cardinal Consulting, outside the submitted work. Dr Wermer has nothing to disclose. Dr Ko reports grants from National Institutes of Health/NINDS, other from Edge Therapeutics, during the conduct of the study. Dr Murayama reports grants and personal fees from Stryker Neurovascular, grants from Siemens Healthcare, and personal fees from Kaneka Medics, during the conduct of the study.
Ethical approval/informed consent
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Unruptured Cerebral Aneurysms and SAH CDE Project Investigators members are listed in Appendix.
Appendix: UIA and SAH Working Group Members
Appendix: UIA and SAH Working Group Members
Steering Committee
Jose I Suarez, MD, FNCS, FANA, Johns Hopkins University School of Medicine, Baltimore, MD, co - Chair
R Loch Macdonald, MD, PhD, University of Toronto, Toronto, ON, Canada, co - Chair
Sepideh Amin-Hanjani, MD, University of Illinois at Chicago, Chicago, IL
Robert D. Brown, Jr., MD, MPH, Mayo Clinic, Rochester, MN
Airton Leonardo de Oliveira Manoel, MD, PhD, University of Toronto, Toronto, Ontario, Canada
Colin P Derdeyn, MD, FACR, University of Iowa, Carver College of Medicine, Iowa City, IA
Nima Etminan, MD, University Hospital Mannheim, Mannheim, Germany
Emanuela Keller, MD, University of Zurich, Zurich, Switzerland
Peter D. LeRoux, MD, FACS, Main Line Health, Wynnewood, PA
Stephan Mayer, MD, Henry Ford Hospital, Detroit, MI
Akio Morita, MD, PhD, Nippon Medical School, Tokyo, Japan
Gabriel Rinkel, MD, University Medical Center, Utrecht, The Netherlands
Daniel Rufennacht, MD, Klinik Hirslanden, Zurich, Switzerland
Martin N. Stienen, MD, FEBNS, University of Zurich, Zurich, Switzerland
James Torner, MSc, PhD, University of Iowa, Iowa City, IA
Mervyn D.I. Vergouwen, MD, PhD, University Medical Center, Utrecht, The Netherlands
George K. C. Wong, MD, Chinese University of Hong Kong, Shatin, Hong Kong
Subject Characteristics Working Group
Robert D. Brown, Jr., MD, MPH, Mayo Clinic, Rochester, MN, co-Chair
Akio Morita, MD, PhD, Nippon Medical School, Tokyo, Japan, co-Chair
Philippe Bijlenga, MD, PhD, Geneva University Hospital, Geneva, Switzerland (Superuser)
Nerissa Ko, MD; Cameron G McDougall, MD; J Mocco, MS, MD; Yuuichi Murayama, MD; Marieke J H Werner, MD, PhD
Assessments and Examinations Working Group
Stephan Mayer, MD, Henry Ford Hospital, Detroit, MI, co-Chair
Jose I Suarez, MD, FNCS, FANA, The Johns Hopkins University School of Medicine, Baltimore, MD, co-Chair
Rahul Damani, MD, MPH, Baylor College of Medicine, Houston, TX (Superuser)
Joseph Broderick, MD; Raj Dhar, MD, FRCPC; Edward C Jauch, MD, MS, FACEP, FAHA; Peter J Kirkpatrick; Renee H Martin, PhD; J Mocco, MS, MD; Susanne Muehlschlegel, MD, MPH; Tatsushi Mutoh, MD, DVM, PhD; Paul Nyquist, MD, MPH; Daiwai Olson, RN, PhD; Jorge H Mejia-Mantilla, MD, MSc.
Hospital Course and Acute Therapies Working Group
Sepideh Amin-Hanjani, MD, University of Illinois at Chicago, Chicago, IL, co-Chair
Airton Leonardo de Oliveira Manoel, MD, PhD, University of Toronto, Toronto, Ontario, Canada, co-Chair (Superuser)
Mathieu van der Jagt, MD, PhD, Erasmus Medical Center, Rotterdam, The Netherlands (Superuser)
Nicholas Bambakidis, MD; Gretchen Brophy, PharmD, BCPS, FCCP, FCCM, FNCS; Ketan Bulsara, MD; Jan Claassen, MD, PhD; E Sander Connolly, MD, FACS; S Alan Hoffer, MD; Brian L Hoh, MD, FACS; Robert G Holloway, MD, MPH; Adam Kelly, MD; Stephan Mayer, MD; Peter Nakaji, MD; Alejandro Rabinstein, MD; Jose I Suarez, MD, FNCS, FANA; Peter Vajkoczy, MD; Mervyn D. I. Vergouwen, MD, PhD; Henry Woo, MD; Gregory J Zipfel, MD.
Biospecimens and Biomarkers Working Group
Emanuela Keller, MD, University of Zurich, Zurich, Switzerland, co-Chair (Superuser)
R Loch Macdonald, MD, PhD, University of Toronto, Toronto, ON, Canada, co-Chair
Sherry Chou, MD, MMSc; Sylvain Doré, PhD, FAHA; Aaron S Dumont, MD; Murat Gunel, MD, FACS, FAHA; Hidetoshi Kasuya, MD; Alexander Roederer, PhD; Ynte Ruigrok, MD; Paul M Vespa, MD, FCCM, FAAN, FANA, FNCS; Asita Simone Sarrafzadeh-Khorrasani, PhD.
Imaging Working Group
Colin P Derdeyn, MD, FACR, University of Iowa, Carver College of Medicine, Iowa City, IA, co-Chair
Nima Etminan, MD University Hospital Mannheim, Mannheim, Germany, co-Chair
Katharina Hackenberg, MD, University Hospital Mannheim, Mannheim, Germany (Superuser)
John Huston, III, MD; Timo Krings, MD, PhD, FRCPC; Giuseppe Lanzino, MD; Philip M Meyers, MD, FACR, FSIR, FAHA; Gabriel Rinkel, MD; Daniel Rufennacht, MD; Max Wintermark, MD.
Long-Term Therapies Working Group
James Torner, MSc, PhD, University of Iowa, Iowa City, IA, co-Chair (Superuser)
George K. C. Wong, MD, Chinese University of Hong Kong, Shatin, Hong Kong, co-Chair (Superuser)
Joseph Broderick, MD; Janis Daly, PhD, MS; Christopher Ogilvy, MD; Denise H Rhoney, PharmD, FCCP, FCCM, FNCS; YB Roos, PhD; Adnan Siddiqui, MD, PhD, FAHA.
Unruptured Intracranial Aneurysms Working Group
Nima Etminan, MD, University Hospital Mannheim, Mannheim, Germany, co-Chair
Gabriel Rinkel, MD, University Medical Center, Utrecht, The Netherlands, co-Chair
Katharina Hackenberg, MD, University Hospital Mannheim, Mannheim, Germany (Superuser)
Ale Algra, MD, FAHA; Juhanna Frösen, MD; David Hasan, MD; Seppo Juvela, MD, PhD; David J Langer, MD; Philip M Meyers, MD, FACR, FSIR, FAHA; Akio Morita, MD, PhD; Rustam Al-Shahi Salman, MA, PhD, FRCP.
Outcomes and Endpoints Working Group
Martin N. Stienen, MD, FEBNS, University of Zurich, Zurich, Switzerland, co-Chair (Superuser)
Mervyn D.I. Vergouwen, MD, PhD, University Medical Center, Utrecht, The Netherlands, co-Chair
Daniel Hanggi, MD; R Loch Macdonald, MD, PhD; Tom Schweizer, PhD; Johanna Visser-Meily, MD, PhD.
National Library of Medicine CDE Team
Liz Amos, MLIS, National Information Center on Health Services Research and Health Care Technology, National Library of Medicine
Christophe Ludet, MS, National Library of Medicine, Bethesda, MD
NINDS CDE Team
Claudia Moy, PhD, NINDS, Bethesda, MD
Joanne Odenkirchen, MPH, NINDS, Bethesda, MD
Sherita Ala’i, MS, The Emmes Corporation, Rockville, MD
Joy Esterlitz, MS, The Emmes Corporation, Rockville, MD
Kristen Joseph, MA, The Emmes Corporation, Rockville, MD
Muniza Sheikh, MS, MBA, The Emmes Corporation, Rockville, MD
Rights and permissions
About this article
Cite this article
Bijlenga, P., Morita, A., Ko, N.U. et al. Common Data Elements for Subarachnoid Hemorrhage and Unruptured Intracranial Aneurysms: Recommendations from the Working Group on Subject Characteristics. Neurocrit Care 30 (Suppl 1), 20–27 (2019). https://doi.org/10.1007/s12028-019-00724-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-019-00724-5